These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 14740248

  • 1. Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations.
    Muir T, Kirsten M, Fourie P, Dippenaar N, Ionescu GO.
    Pediatr Surg Int; 2004 Jan; 19(12):766-73. PubMed ID: 14740248
    [Abstract] [Full Text] [Related]

  • 2. Noninvasive management of hemangioma and vascular malformation using intralesional bleomycin injection.
    Hassan Y, Osman AK, Altyeb A.
    Ann Plast Surg; 2013 Jan; 70(1):70-3. PubMed ID: 23249476
    [Abstract] [Full Text] [Related]

  • 3. Intralesional bleomycin injection treatment for vascular birthmarks: a 5-year experience at a single United Kingdom unit.
    Sainsbury DCG, Kessell G, Fall AJ, Hampton FJ, Guhan A, Muir T.
    Plast Reconstr Surg; 2011 May; 127(5):2031-2044. PubMed ID: 21532430
    [Abstract] [Full Text] [Related]

  • 4. [Bleomycin therapy for lymphangioma].
    Kertész Z, Bălă G, Bancu S, Gozar H, Virgil G, Horváth E, Pávai Z.
    Chirurgia (Bucur); 2011 May; 106(1):103-7. PubMed ID: 21523964
    [Abstract] [Full Text] [Related]

  • 5. Intralesional bleomycin injection in management of low flow vascular malformations in children.
    Mohan AT, Adams S, Adams K, Hudson DA.
    J Plast Surg Hand Surg; 2015 Apr; 49(2):116-20. PubMed ID: 25204206
    [Abstract] [Full Text] [Related]

  • 6. Treatment of cystic hygroma by intralesional bleomycin injection: experience in 70 patients.
    Niramis R, Watanatittan S, Rattanasuwan T.
    Eur J Pediatr Surg; 2010 May; 20(3):178-82. PubMed ID: 20178075
    [Abstract] [Full Text] [Related]

  • 7. Intralesional bleomycin and sodium tetradecyl sulphate for haemangiomas and lymphangiomas.
    Harjai MM, Jha M.
    Afr J Paediatr Surg; 2012 May; 9(1):47-51. PubMed ID: 22382104
    [Abstract] [Full Text] [Related]

  • 8. Treatment of orbital vascular malformations with intralesional injection of pingyangmycin.
    Yue H, Qian J, Elner VM, Guo J, Yuan YF, Zhang R, Ge Q.
    Br J Ophthalmol; 2013 Jun; 97(6):739-45. PubMed ID: 23603483
    [Abstract] [Full Text] [Related]

  • 9. Intralesional injection of Pingyangmycin for vascular malformations in oral and maxillofacial regions: an evaluation of 297 consecutive patients.
    Zheng JW, Yang XJ, Wang YA, He Y, Ye WM, Zhang ZY.
    Oral Oncol; 2009 Oct; 45(10):872-6. PubMed ID: 19628423
    [Abstract] [Full Text] [Related]

  • 10. Bleomycin electrosclerotherapy: new treatment to manage vascular malformations.
    McMorrow L, Shaikh M, Kessell G, Muir T.
    Br J Oral Maxillofac Surg; 2017 Nov; 55(9):977-979. PubMed ID: 29055573
    [Abstract] [Full Text] [Related]

  • 11. Single center experience with intralesional bleomycin sclerotherapy for lymphatic malformations.
    Yılmaz H, Yılmaz Ö, Çamlıdağ İ, Belet Ü, Akan H.
    Jpn J Radiol; 2017 Oct; 35(10):590-596. PubMed ID: 28779454
    [Abstract] [Full Text] [Related]

  • 12. Bleomycin plasma spill-over levels in paediatric patients undergoing intralesional injection for the treatment of haemangiomas.
    Ionescu G, Mabeta P, Dippenaar N, Muir T, Fourie P, Shelver G.
    S Afr Med J; 2008 Jul; 98(7):539-40. PubMed ID: 18785394
    [No Abstract] [Full Text] [Related]

  • 13. Therapeutic Effects of Intralesional Bleomycin Sclerotherapy for Non-Invasive Management of Low Flow Vascular Malformations - A Prospective Clinical Study.
    Jan I, Shah A, Beigh SH.
    Ann Maxillofac Surg; 2022 Jul; 12(2):151-156. PubMed ID: 36874789
    [Abstract] [Full Text] [Related]

  • 14. Role of intralesional bleomycin in the treatment of complicated hemangiomas: prospective clinical study.
    Omidvari S, Nezakatgoo N, Ahmadloo N, Mohammadianpanah M, Mosalaei A.
    Dermatol Surg; 2005 May; 31(5):499-501. PubMed ID: 15962730
    [Abstract] [Full Text] [Related]

  • 15. [Local injection of bleomycin A 5 in children with hemangiomas. Analysis of 210 cases].
    Zheng QT.
    Zhonghua Wai Ke Za Zhi; 1991 May; 29(5):290-1, 334. PubMed ID: 1717207
    [Abstract] [Full Text] [Related]

  • 16. Infantile hemangioma: Efficacy of low-dose propranolol and of intralesional bleomycin injection for propranolol non-response.
    Düzenli Kar Y, Özdemir ZC, Acu B, Bör Ö.
    Pediatr Int; 2019 May; 61(5):459-464. PubMed ID: 30861274
    [Abstract] [Full Text] [Related]

  • 17. Role of intralesional bleomycin sclerotherapy as the sole or adjunct treatment of superficial ocular adnexal lymphatic malformations.
    Bothra N, Panda L, Sheth J, Tripathy D.
    Eye (Lond); 2018 Jan; 32(1):152-155. PubMed ID: 28776595
    [Abstract] [Full Text] [Related]

  • 18. The effects of Bleomycin A5 on infantile maxillofacial haemangioma.
    Luo QF, Zhao FY.
    Head Face Med; 2011 Jul 07; 7():11. PubMed ID: 21736714
    [Abstract] [Full Text] [Related]

  • 19. Long-term results of intratumorous bleomycin-A5 injection for head and neck lymphangioma.
    Zhong PQ, Zhi FX, Li R, Xue JL, Shu GY.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Aug 07; 86(2):139-44. PubMed ID: 9720086
    [Abstract] [Full Text] [Related]

  • 20. Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck.
    Mathur NN, Rana I, Bothra R, Dhawan R, Kathuria G, Pradhan T.
    Int J Pediatr Otorhinolaryngol; 2005 Jan 07; 69(1):75-80. PubMed ID: 15627451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.